SN

Sivakumar Narasimhan

Active Director Managing Director DIN 02673314
DIN 02673314 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since May 2009
Shareholding value •••• Premium profile

About Sivakumar Narasimhan

Data last updated:

Sivakumar Narasimhan is a Managing Director at Avis Healthcare Private Limited (since 2012), Whole-Time Director at New Rrpd Private Limited (since 2021) and Director at New Siva Agencies Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹101 Cr; the largest is Avis Healthcare Private Limited at ₹43.90 Cr (FY 2025). Earlier, Sivakumar Narasimhan was a Director at Transworld Pharma (Madras) Private Limited (2009–2010).

DIN 02673314
Primary Designation Managing Director
Industry Pharma
First Appointment 28 May 2009
Oldest Company Age 13 yrs
Largest company Avis Healthcare Private Limited · ₹43.90 Cr (FY 2025)
Combined revenue ₹101 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avis Healthcare Private Limited U52310TN2012PTC088536
Managing Director16 Nov 20122012₹43.90 Cr (FY 2025)Active
New Rrpd Private Limited U51397TN2021PTC147584
Whole-Time Director01 Nov 20212021₹30.83 Cr (FY 2025)Active
New Siva Agencies Private Limited U51909TN2021PTC147738
Director12 Dec 20232021₹26.54 Cr (FY 2025)Active
Cpd Pharma Private Limited U51909TN2019PTC130073
Director04 Jan 20242019₹90,000 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20091985₹7.56 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avis Healthcare Private Limited
Cpd Pharma Private Limited
New Rrpd Private Limited
New Siva Agencies Private Limited
Premium access

Shareholding and investment profile for Sivakumar Narasimhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivakumar Narasimhan

Sivakumar Narasimhan currently holds 4 directorships: Avis Healthcare Private Limited (Managing Director, since 16 Nov 2012, revenue ₹43.90 Cr (FY 2025)); New Rrpd Private Limited (Whole-Time Director, since 01 Nov 2021, revenue ₹30.83 Cr (FY 2025)); New Siva Agencies Private Limited (Director, since 12 Dec 2023, revenue ₹26.54 Cr (FY 2025)); Cpd Pharma Private Limited (Director, since 04 Jan 2024, revenue ₹90,000 (FY 2025)).

Sivakumar Narasimhan was first appointed on 28 May 2009 as Director at Transworld Pharma (Madras) Private Limited. The most recent appointment on record is 04 Jan 2024 at Cpd Pharma Private Limited.

The 4 current companies of Sivakumar Narasimhan that report revenue have a combined latest revenue of ₹101 Cr: Avis Healthcare Private Limited ₹43.90 Cr (FY 2025); New Rrpd Private Limited ₹30.83 Cr (FY 2025); New Siva Agencies Private Limited ₹26.54 Cr (FY 2025); Cpd Pharma Private Limited ₹90,000 (FY 2025).

Sivakumar Narasimhan held 1 earlier board appointment: Transworld Pharma (Madras) Private Limited (Director, 28 May 2009 to 01 Jun 2010).

The current boards of Sivakumar Narasimhan's companies include Deepak Sivakumar (Avis Healthcare Private Limited), Shakila Sivakumar (Avis Healthcare Private Limited), Sivakumar Gowtham (Avis Healthcare Private Limited), Abhinav Choudhary (New Rrpd Private Limited), Karthik (New Rrpd Private Limited), Katragadda Raja Venkata Subrahmanya Varaprasad (Cpd Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available